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Introduction
Although invasive intracranial pressure monitoring
(ICPM) has been a mainstay in the management of trau-
matic brain injury for a number of years, its use in an
elective or emergency setting to guide management of
patients with hydrocephalus and other CSF disorders is a
relatively new concept. This single centre experience
examines the safety profile and utility of ICPM in this
patient population.
Methods
We retrospectively reviewed all cases of monitoring over
a 10 year period at the National Hospital for Neurology
and Neurosurgery, London, UK. 338 cases were identi-
fied. Case records were reviewed for diagnosis, indication
of ICPM, duration, complications and outcome. All
operations utilised Spiegelberg ICP monitors, inserted in
a protocolised fashion under sedation.
Results
ICPM was undertaken for a number of different conditions
including undiagnosed headache (20.4%), IIH (28.7%),
NPH (5.3%), high-pressure hydrocephalus (eg congenital/
post-traumatic/post-SAH) (17.2%) and Chiari malforma-
tions/syringomyelia (13.6%). Indications for ICPM included
headache (74.0%), visual disturbance (6.2%), gait distur-
bance (6.2%) and cognitive disturbance (5.0%). Mean moni-
toring time was 37.3 hrs (range 12-154 hrs). Monitoring
was conducted in the presence of a CSF shunt (50.6%),
venous stent (3.7%) and previous cranial decompression
(6.5%). Dynamic monitoring (eg with different shunt set-
tings or pre/post venous stent insertion) was undertaken in
12.4%. Outcomes from ICPM included insertion of new
CSF shunt (21.0%), revision of CSF shunt (13.0%), insertion
of venous stent (6.5%), insertion of and lumbar drains for
infusion studies (3.6%); importantly, non-operative treat-
ment was pursued in a number of cases including shunt
valve adjustment (7.7%) and conservative management
(29.9%). Complications included superficial infection
(4 patients, 1.2%), symptomatic intracerebral haematoma
(1 patient, 0.3%) and misplacement (3 patients, 0.9%);
importantly, there were no cases of deep intracranial infec-
tion and the only case of seizures was in the patient with
the intracerebral haematoma.
Conclusion
This is the largest known series of ICPM for CSF disor-
ders. It shows that ICP monitoring is a safe procedure
and may be undertaken as part of routine protocol in
the management of complex hydrocephalus patients.
The number of cases that were subsequently managed
conservatively or with a simple valve adjustment (37.6%)
indicates the utility in terms of reducing operative inter-
ventions. Further evaluation of positive and negative
predictive values based on the results of ICP monitoring
and health-economic analyses will push the case for
routine ICP monitoring prior to definitive management
of all hydrocephalus patients.
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